Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Conference abstract · 12 Nov 2018Exact title match Review article · 16 Mar 2013Exact title match PROSTATE CANCER
Conference abstract · 2020 Effect of exercise on cancer-related fatigue (CRF) in patients with prostate cancer: a systematic review
explore the effect of exercise on cancer-related fatigue in patients with prostate cancer, and to provide a theoretical basis for the symptom management of cancer-related fatigue. Methods ... CCTs of evaluating the…
Conference abstract · 29 Nov 2017 Identification of active compounds for the development of new anti-prostate cancer drugs: Comparative study in yeast and human cells
More than 70% of prostate cancer (PCa) patients display loss or reduction of BRCA2 protein, an onco-suppressor involved in DNA repair through homologous recombination. We have shown that loss ... following androgen…
Conference abstract · 2018 The Effect of the Anti-Cancer Preparation NSC-631570 on Prostate Cancer
protective effect was found in normal human fibroblasts. NSC 631570 caused the accumulation of prostate cancer cells as well as epidermoid carcinoma cells in the G2/M phase, however ... normal cells. The efficacy of…
Conference abstract · 20 Mar 2017 Identification of Expression of Putative Cancer Stem Cell Markers in Prostate Cancer
Advanced prostate cancer (PCa) is androgen-independent. Studies revealed that tumor–initiating cells negative for androgen receptor (AR-) and p63, express the markers for cancer stem cells (CSCs). Recent studies…
Conference abstract · Dec 2018 Soluble E-cadherin in prostate cancer as a serum biomarker in contrast to prostate specific antigen
Histopathology is gold standard in diagnosis of prostate cancer, but it is a cumbersome method. On the other hand, prostate specific screening has revolutionized in detection of prostate cancer ... level of soluble…
Conference abstract · 25 Jul 2016 Loss of ETV6 expression results in aggressive prostate cancer progression: Modeling through prostate cancer cell lines
functions and regulating signaling remain unclear. In this study, we demonstrate that ETV6 represses prostate cancer metastasis. We identified miR-96, a potential oncomiR, as a novel target of epidermal ... growth…
Review article · 30 Nov 2020 Role of Mitochondrial Zinc in Progression of Prostate Cancer: A Diagnostic Biomarker for Prostate Cancer
peripheral, central zone and a periurethral region. Biomarkers development for screening and detection of prostate cancer proved crucial in its easy and early management. Mitochondrial Zinc plays a crucial role…
Perspective · 8 Aug 2016 Prostate cancer: incorporating genomic biomarkers in prostate cancer decisions
Prostate cancer is the most common solid tumor malignancy among men in the western world. Even without treatment, PCa-specific mortality rates at 5 and 10 years remain low. Nonetheless
Editorial · 21 Jun 2023 The State of Prostate Cancer Around the World - Advances in Prostate Cancer
Prostate cancer remains a significant global health concern, affecting millions of individuals worldwide, is the most frequently diagnosed cancer and the sixth leading cause of cancer-related deaths globally…
Review article · 7 Jun 2023 Prostate cancer stem cells: their role in prostate cancer and new therapies to target them
Prostate Cancer (PCa) is the second most common cancer and the sixth leading cause of cancer death in men worldwide. Prostate Cancer Stem cells (PCSC) play an important role ... resistance to standard cancer…
Conference proceeding · 26 Oct 2020 High Levels of the PSA (Prostate Specific Antigen) in Patients with Benign Prostatic Hyperplasia and Prostate Cancer
evaluate high levels of PSA(Prostate specific antigen) in BPH(benign prostatic hyperplasia), prostate cancer, chronic and granulomatous Benign Prostatic Hyperplasia, Chronic and Granulomatous Prostatitis and Prostate…
Research article · 11 Jan 2018 Risk of Developing Second Primary Prostatic Cancer in Patients with Previously Treated Prostatic Cancer: A Retrospective Cohort Study
Objective: The present study aims to investigate the risk of developing second primary prostate cancer after treating initial primary prostate cancer and to determine the role played by different variables ... have…
Conference abstract · 29 May 2017 Bone Microenvironment Targeted Nanoparticles for Metastatic Prostate Cancer Treatment
Purpose The most common site of metastatic prostate cancer is the bone. These metastatic lesions are difficult to treat and often result in off target cytotoxicity from current chemotherapeutics ... spheroids. Finally…
Conference abstract · 3 Sep 2018 Precision management in castration resistant prostate cancer (CRPC) : A theranostic approach
therapy with the same vector. This concept is utilized in few malignancies and prostate cancer is one of them. PSMA expression in normal and other tumor is less than prostate ... staging . Besides evaluation of…
Research article · 2014 Efficacy of Supportive Histo-morphological Features in Prostate Cancer Diagnosis
Abstract: Prostate cancer is a major disease of concern in adult males. Histological architectural heterogeneity has rendered challenges to diagnosis. Definitive diagnosis has been relied on Pathologist subjectivity…
Conference abstract · 4 May 2020 Targeting Prostate Cancer Cells with Hybrid Elastin-Like Polypeptide/Liposome Nanoparticles
long time, prostate cancer has been considered chemo-refractory. Only during the last 10-15 years, have good results been achieved in clinic trials with taxane derivatives such as docetaxel ... limit optimal dosage and…
Conference abstract · 11 Jul 2016 The negative impact of tobacco smoking on survival after prostate cancer diagnosis.
Purpose: Tobacco smoking has been found to increase prostate cancer (PCa) mortality in cohorts of healthy men but its effects on prognosis of men with PCa are still unclear. This
Research article · 2 Apr 2013 MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3
examined microRNA-181b (miRNA) expression in prostate cancer tissues and its effect on the prostate cancer cell line PC-3. Tissues from 27 cases of prostate cancer and 30 samples ... 181b was quantified using RT-PCR…
Conference abstract · 2018 Utility of bone scan quantitative parameters for the evaluation of prostate cancer patients
Prostate Cancer is one of the common cancers in the world. It could primarily disseminate to the bone and can lead to death. In order to address its life threatening ... individual methods reported in literature and…
Conference abstract · 18 Oct 2017 Prostate cancer gene expression panel to address racial differences of molecular alterations in prostate cancer
Introduction and Objectives: Prostate cancer (CaP) affects 1 in 7 men in their life time. African American (AA) men have significantly higher incidence and mortality from CaP compared to Caucasian
Research article · 6 Mar 2016 Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases
Bone metastasis is a common complication in prostate cancer patients that can cause bone pain and pathological fracture. This study tested serum levels of prostate specific antigen (PSA), alkaline phosphatase ... bone…
Research article · 15 Feb 2021 Novel therapeutic anticancer property of Vernonia amygdalina Delile towards the treatment of prostate cancer
Prostate cancer is one of the common cancers in males and its incidence keeps increasing globally. Approximately 81% of prostate cancer is diagnosed during the early stage of the disease ... that is relatively…
Conference abstract · Aug 2020 MICRORNA’S SIGNATURE AND IT’S ROLE IN CARCINOGENESIS FOR BIOMAKER OF PROSTATE CANCER
usual diagnostic method to diagnostic Prostate cancer is the PSA (prostate specific antigen) method. However this method is considered to be less effective because the interpretation of the value ... this study is to…
Conference abstract · 24 Jan 2020 Targeting to prostate cancer cells by using ligand conjugated polymeric nanoparticles as drug carrier
overcome the lack of specificity of conventional chemotherapeutic agents for the treatment of prostate cancer, the second most common cancer in men. The aim of the current study ... nanoparticles will be conjugated with…
Conference abstract · 14 Sep 2016 Unraveling tumor heterogeneity in prostate cancer by combined immunohistochemistry and RNA in situ hybridization |
Prostate cancer (PCa) remains the most commonly diagnosed cancer in American men with an estimated incidence of 220,800 new cases and accounting for 27,540 cancer related deaths ... cell diagnostics. Further, with…

